JC
APGN

JBF Capital’s Apexigen, Inc. Common Stock APGN Stock Holding History

JBF Capital’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,130
Closed -$3.92K – 80
2023
Q2 		$3.92K Buy
+9,130
New +$4.32K ﹤0.01% 75

JBF Capital's APGN Position: Q3 2023 in Review

JBF Capital sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2023, closing a stake of 9,130 shares — an estimated $3.92K sold.

JBF Capital first reported a position in APGN in Q2 2023 and held it in 1 quarter. The position peaked at $3.92K in Q2 2023. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

  • JBF Capital reported no remaining Apexigen, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • JBF Capital sold 9,130 Apexigen, Inc. Common Stock shares in Q3 2023, an estimated $3.92K.
  • JBF Capital first reported a position in Apexigen, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • JBF Capital's Apexigen, Inc. Common Stock position peaked at $3.92K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2023.

Based on JBF Capital's 13F filing for Q3 2023, filed 14 Nov 2023.